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Like their Au(I) counterparts, silver complexes of the type [M(R’2P(CH2)nPR’" 2)2 exhibit potent
cytotoxicity towards cancer cells in vitro, ,2 in addition, they show antifungal and modest antibacterial
properties.2 However, none of these has reached clinical trials because of extreme mitochondrial
toxicity related to uncoupling of oxidative phosphorylation for the gold(I) analogues.3 We now report
that the Ag(I) complex, [Ag(Et2PCH2CH2PPh2)2]NO3, (I), inhibits the growth of yeast selectively in
non-fermentable media, indicating a primary effect on mitochondrial function. Yeast cells in a
fermentable medium (containing glucose) show a high frequency of the mitochondrial mutation
petite, while toxicity (measured as cell death) is low. Aspirin in the growth medium largely reverses
the antimitochondrial effects of the complex. The chemistry of this complex and the implications for
drug design will be discussed.
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